Affymetrix Reports Profitable Q4: Plans To Expand into Europe, Genotyping | GenomeWeb

In the last quarter, Affymetrix seemingly crossed over to that Zion that eludes most genomics companies, reporting a profit for the first time in its ten-year history.

Last week, the company reported a pro forma profit of $744,000 for the fourth quarter of 2001, and projected that it will see a $3million to $5 million pro forma profit for 2002, on revenues 25 percent above last year’s.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.